sun 1165

Small moleculeexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2012 (NCT01775891)

Timeline

No events for the selected filters.

Chemistry & pharmacology

Loading structure…

SMILES

Cc1cccc(C)c1NC(=O)CC12CCCN1CCC2
Mol. weight
272.39 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1h-pyrrolizine-7a(5h)-acetamide, n-(2,6-dimethylphenyl)tetrahydro-, hydrochloride (1:1)
  • 1h-pyrrolizine-7a(5h)-acetamide, n-(2,6-dimethylphenyl)tetrahydro-, hydrochloride hemihydrate
  • n-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide
  • pilsicainide hcl
  • pilsicainide hydrochloride
  • pilsicainide hydrochloride
  • pilsicainide hydrochloride hemihydrate
  • pilsicainide hydrochloride hemihydrate
  • pilsicainide hydrochloride hydrate
  • pilsicainide hydrochloride hydrate
  • pilzicainide
  • sun 1165
  • sun 1165
  • sun-1165
  • tetrahydro-1h-pyrrolizine-7a(5h)-aceto-2',6'-xylidide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01775891N/AJul 1, 2012Korea University
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Korea UniversityAcademic/Hospital1112012
1 organizations
Page 1 / 1